Michael D. West
2019 - Serina Therapeutics
In 2019, Michael D. West earned a total compensation of $1M as Chief Executive Officer at Serina Therapeutics, a 37% decrease compared to previous year.
Compensation breakdown
| Option Awards | $484,647 |
|---|---|
| Salary | $543,054 |
| Other | $14,000 |
| Total | $1,041,701 |
West received $543.1K in salary, accounting for 52% of the total pay in 2019.
West also received $484.6K in option awards and $14K in other compensation.
Rankings
In 2019, Michael D. West's compensation ranked 9,110th out of 13,971 executives tracked by ExecPay. In other words, West earned more than 34.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,110 out of 13,971 | 35th |
Division Manufacturing | 3,655 out of 5,701 | 36th |
Major group Chemicals And Allied Products | 1,383 out of 2,200 | 37th |
Industry group Drugs | 1,180 out of 1,886 | 37th |
Industry Pharmaceutical Preparations | 874 out of 1,398 | 38th |
Source: SEC filing on November 24, 2020.
West's colleagues
We found three more compensation records of executives who worked with Michael D. West at Serina Therapeutics in 2019.
News
Serina Therapeutics CEO Michael West's 2020 pay falls 46% to $561K
November 24, 2021
Serina Therapeutics CEO Michael West's 2019 pay falls 24% to $1M
November 24, 2020
Serina Therapeutics CEO Michael West's 2018 pay rises 2% to $1.7M
November 29, 2019
BioTime CEO Brian Culley's 2018 pay jumps 75% to $2.8M
June 14, 2019